Research ArticleClinical Studies
Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM
DIRK RADES, LENA SEHMISCH, HEINKE C. HANSEN, LIESA DZIGGEL, STEFAN JANSSEN and STEVEN E. SCHILD
Anticancer Research March 2019, 39 (3) 1501-1505; DOI: https://doi.org/10.21873/anticanres.13268
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
LENA SEHMISCH
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
HEINKE C. HANSEN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
LIESA DZIGGEL
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
STEFAN JANSSEN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
2Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany
STEVEN E. SCHILD
3Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
In this issue
Anticancer Research
Vol. 39, Issue 3
March 2019
Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM
DIRK RADES, LENA SEHMISCH, HEINKE C. HANSEN, LIESA DZIGGEL, STEFAN JANSSEN, STEVEN E. SCHILD
Anticancer Research Mar 2019, 39 (3) 1501-1505; DOI: 10.21873/anticanres.13268
Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM
DIRK RADES, LENA SEHMISCH, HEINKE C. HANSEN, LIESA DZIGGEL, STEFAN JANSSEN, STEVEN E. SCHILD
Anticancer Research Mar 2019, 39 (3) 1501-1505; DOI: 10.21873/anticanres.13268
Jump to section
Related Articles
- No related articles found.
Cited By...
- Radiotherapy of Grade III Gliomas: Identification of Clinical Prognostic Factors for Local Tumor Control and Survival
- A Simple Implement for Assessing the Survival of Elderly Patients With Melanoma Irradiated for Cerebral Metastases
- Interval Between Cancer Diagnosis and Radiotherapy - An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney Cancer